Introduction {#S1}
============

Sphingosine-1-phosphate (S1P), a sphingolipid, is one of the essential modulators of various cellular processes such as differentiation, survival, growth, etc. ([@B1]). Sphingolipids are recently termed as "morphogenetic lipids" for their crucial role in embryonic stem cell differentiation, survival, and postnatal development ([@B53]). It was recently demonstrated that S1P plays an important role in allergic anaphylaxis and asthma ([@B48]; [@B20]). Asthma is a heterogeneous and complex disease typically characterized by bronchial hyperactivity, remodeling of lung tissues, and chronic bronchial inflammation ([@B33]). Importantly, asthma is predisposed by both genetic and environmental factors and the incidence of Asthma has been ever increasing in both children and adults around the globe ([@B6]; [@B31]). Approximately 1000 people die each day due to Asthma and there were 339.4 million people affected by asthma globally in 2016. This represents a 3.6% increase in age-standardized prevalence since 2006 ([@B14]; [@B15]). Asthma affects individuals of all ages and all ethnicity and the economic burden of respiratory diseases to governments, healthcare systems, families, and patients are on the rise globally ([@B49]; [@B11]). Hence, creating new applied scientific knowledge in the area of asthma and related respiratory diseases has become a key priority around the globe ([@B11]; [@B24]).

S1P is the ligand for G-protein coupled receptors (GPCRs) that belong to the Endothelial Differentiation Gene (EDG) family of proteins termed as S1P receptors (S1PRs) ([@B52]; [@B17]; [@B50]; [@B1]). S1P can specifically stimulate distinct genetic events depending on the relative expression of S1PRs as well as downstream G-proteins ([@B4]; [@B1]; [@B29]). The intracellular S1P is transported through ATP binding cassette transporter, ABCC1 to the extracellular milieu ([@B34]; [@B37]) and causes the chemotaxis of inflammatory cells that is a pre-requisite for *T*-lymphocyte exit from primary and secondary lymph organs ([@B1]). It was shown that the S1P/S1PR axis is important for the initiation of various pathophysiological processes that possibly leading to critical diseases such as cancer, inflammatory diseases, and disorders in humans and other higher eukaryotes ([@B1]). Recently, FDA has approved the first oral drug, named Gilenya (FTY720 or Fingolimod), a sphingosine analog for the treatment of relapse in Multiple Sclerosis (MS) ([@B1]). The sphingolipid metabolism was significantly affected in asthma and the S1P levels were increased and correlated with the severity of the disease ([@B35]; [@B46]). The clinical phenotypes of asthma with distinct disease mechanisms are critically influenced by levels of sphingolipid metabolites such as S1P ([@B31]). It was shown that the changes in sphingolipid metabolism and airway hyperresponsiveness were positively correlated in patients suffering from dust mite allergy and the intravascular levels of both sphinganine-1-phosphate (SA1P) and S1P, were significantly associated with the severity of bronchial hyperreactivity ([@B25]). The phenotypes of asthma may be distinct based on the levels of sphingolipid metabolites and the change in sphingolipids could represent a pathophysiological variation in bronchial hypersensitivity to allergens in asthmatics ([@B31]).

To address this important problem, we have designed this study to delineate the functions of S1P in the development of asthma and other respiratory diseases. Here, we have utilized both next-generation knowledge discovery platforms such as SwissTargetPrediction, WebGestalt, Open Targets Platform, and Ingenuity Pathway Analysis (Qiagen, United States) to delineate the molecular targets of S1P and validated the upstream regulators of S1P signaling using cutting edge multiple analyte profiling (xMAP) technology (Luminex Corporation, United States) ([@B5]; [@B41]; [@B16]; [@B19]).

Materials and Methods {#S2}
=====================

SwissTargetPrediction Analysis {#S2.SS1}
------------------------------

The *in silico* prediction of the molecular targets of S1P was performed using Swiss Target Prediction, a virtual screening web tool ([@B13]). Both canonical and isomeric SMILES of S1P were used as an input sequence as described before ([@B9]). In the SwissTargetPrediction web tool, the similarity principle is used to predict the targets by reverse screening strategy. In the SwissTargetPrediction web tool, the predictions are performed from analogous molecules in 2D and 3D, from 376342 experimentally active compounds that are significantly interacting with 3068 known macromolecular targets ([@B10]).

WebGestalt Analysis of S1P Targets {#S2.SS2}
----------------------------------

The Over Representation Analysis (ORA) of the molecular targets of S1P derived using Swiss Target Prediction was used in the WebGestalt tool (wGSEA) ([@B57]; [@B54], [@B55]; [@B27]). Using wGSEA gene lists obtained from large scale -omics studies were categorized based on biological, molecular, and cellular functions. wGSEA is a freely available open-source platform^[1](#footnote1){ref-type="fn"}^ that enables a more broad, effective, flexible, and interactive functional enrichment study ([@B27]). The latest version of the wGSEA recognizes 155175 functional categories, 342 gene identifiers, and 12 organisms including many user-defined functional databases ([@B27]).

To functionally characterize the S1P-induced molecular profile, we analyzed the molecular targets of S1P obtained by Swiss Target Prediction using ORA (Liao et al., 209). Here, the enrichment method was chosen as ORA, the selected organism was Homo sapiens, and gene ontology (Molecular Function, Biological Function, and Cellular Function) was selected for each type of analysis. The reference list for each analysis included all mapped Entrez gene IDs from the selected platform genome. The parameters for the enrichment analysis included the minimum number of IDs in the category (5), the maximum number of IDs in the category (2000), the Benjamini Hochberg (BH) method (*P* \< 0.05) for computing the False Discovery Rate (FDR) (*P* \< 0.05), and the significance Level (Top 10).

Open Targets Platforms Analysis {#S2.SS3}
-------------------------------

The Open Targets Platform was used to find the S1P molecular targets associated with respiratory diseases ([@B23]; [@B7]; [@B58]). The evidence from scientific literature, animal models, genomics, transcriptomics, genetics, and drugs are used in the Open Targets Platform to score and rank target-disease associations and aid target prioritization ([@B7]; [@B58]). The query list with 93 molecular targets of S1P was used to find the respiratory diseases significantly (*P* \< 0.05) regulated by the S1P signaling and its associated molecular networks.

Ingenuity Pathway Analysis {#S2.SS4}
--------------------------

Ingenuity pathway analysis (IPA) software has a cutting edge up to date next generation knowledge base consists of clarified scientific information from publications, databases, and other relevant resources ([@B19]). Here, we applied the IPA software (Qiagen, United States) to functionally annotate the gene clusters and identified biologically significant pathways regulated by S1P. The molecular target of S1P was subjected to Core Analysis in the IPA to delineate biologically relevant canonical pathways as well as novel molecular signatures, using the right-tailed Fisher Exact Test and Benjamini Hochberg Correction (BHC) for multiple testing (*P* \< 0.05), affecting the respiratory diseases through S1P/SPHK pathway to deduce unique disease-causing gene clusters.

Luminex xMAP Assay for Biomarkers of Asthma {#S2.SS5}
-------------------------------------------

The blood samples were collected from healthy volunteers and asthma patients and both groups were age, and sex-matched. Healthy non-atopic individuals (*n* = 12) were used as control and the asthma patients (*n* = 12) were with moderate to severe disease state, non-smokers, and without any other co-morbid conditions such as chronic obstructive pulmonary disease (COPD), other types of pulmonary diseases and disorders, diabetes, cancer, autoimmune diseases, etc. The institutional ethical approval was obtained before collecting the samples and the study was approved by the Scientific Research Committee, Deanship of Scientific Research (DSR), King Abdulaziz University (KAU), Jeddah. The peripheral blood isolated was kept at room temperature for clotting and then centrifuged at 3000 rpm for 10 min for the separation of serum and the aliquots were stored at −80°C till the xMAP assays were done ([@B5]). The evaluation of cytokines and growth factors filtered using the next-generation knowledge discovery platforms was done in both healthy controls and asthma patients using a multi-cytokine/chemokine (30-plex) magnetic-bead based fluorescence assay and the results were obtained based on the standard curves generated using the 30plex standards (16 plex and 14 plex vials) supplied with the xMAP kit (Catalog No: LHC6003M) (Novex, Invitrogen, United States) using MAGPIX multiplex platform as described before ([@B5]; [@B41]; [@B16]; [@B19]; [@B42]). Serum samples were also used to evaluate the concentration of S1P in both healthy controls and asthma patients using a competitive ELISA method as described before ([@B32]). The absorbance was measured at 450 nm using SpectraMax i3 Multi-Mode Reader with MiniMax Imaging Cytometer (Molecular Devices, United States).

Statistical Analyses {#S2.SS6}
--------------------

The raw xMAP data was analyzed by the xPONENT analysis software (Version 4.2) (Luminex Corporation, Austin, TX, United States) to determine the absolute concentration of cytokines and growth factors in both healthy control and asthma groups ([@B5]; [@B16]; [@B19]). The statistical significance was further computed by using GraphPad Prism Version 8.3 (GraphPad Software, San Diego, CA, United States). *P* ≤ 0.05 was considered to be statistically significant based on the Student's *t*-test (Two Tail). The values were represented as mean ± SD. Furthermore, an *F*-test to compare the variances and simple correlation analysis of S1P levels against cytokines and chemokines in the serum of asthma patients was also performed using GraphPad Prism (Version 8.3) software.

Results {#S3}
=======

*In silico* Prediction of the Molecular Targets of S1P Using SwissTargetPrediction {#S3.SS1}
----------------------------------------------------------------------------------

In the present study, the SwissTargetPrediction was performed for S1P (C18H38NO5P) using both Canonical \[CCCCCCCCCCCCCC = CC(C(COP(= O)(O)O)N)O\] and Isomeric (CCCCCCCCCCCCC/C = C/\[C\@H\](\[C\@H\](COP(= O) (O)O)N)O) Simplified Molecular Input Line Entry System (SMILES) codes ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}) computed by OEChem (Version 2.1.5), have shown that it interacts with 64 and 93 molecules respectively ([Tables 1A,B](#T2){ref-type="table"}) with the highest percentage of binding (46.7 and 53.3%, respectively) with Family A GPCRs ([Figure 1](#F1){ref-type="fig"}).

###### 

SwissTargePrediction of the molecular targets of S1P (Canonical SMILES) in Homo sapiens.

  **Target**                                                    **Common name**   **Uniprot ID**   **ChEMBL ID**   **Target class**                      **Probability**   **Known actives (3D/2D)**
  ------------------------------------------------------------- ----------------- ---------------- --------------- ------------------------------------- ----------------- ---------------------------
  Sphingosine 1-phosphate receptor Edg-8                        S1PR5             Q9H228           CHEMBL2274      Family A G protein-coupled receptor   0.843606914       42/1
  Sphingosine 1-phosphate receptor Edg-6                        S1PR4             O95977           CHEMBL3230      Family A G protein-coupled receptor   0.843606914       40/1
  Sphingosine 1-phosphate receptor Edg-3                        S1PR3             Q99500           CHEMBL3892      Family A G protein-coupled receptor   0.843606914       95/2
  Sphingosine 1-phosphate receptor Edg-1                        S1PR1             P21453           CHEMBL4333      Family A G protein-coupled receptor   0.843606914       123/2
  Sphingosine 1-phosphate receptor Edg-5                        S1PR2             O95136           CHEMBL2955      Family A G protein-coupled receptor   0.783474129       10/1
  Lysophosphatidic acid receptor Edg-7                          LPAR3             Q9UBY5           CHEMBL3250      Family A G protein-coupled receptor   0.097239989       12/10
  Farnesyl diphosphate synthase                                 FDPS              P14324           CHEMBL1782      Transferase                           0                 11/0
  Sphingosine kinase 2                                          SPHK2             Q9NRA0           CHEMBL3023      Enzyme                                0                 0/2
  Sphingosine kinase 1                                          SPHK1             Q9NYA1           CHEMBL4394      Enzyme                                0                 0/3
  Lysophosphatidic acid receptor Edg-2                          LPAR1             Q92633           CHEMBL3819      Family A G protein-coupled receptor   0                 10/5
  Squalene synthetase (by homology)                             FDFT1             P37268           CHEMBL3338      Enzyme                                0                 1/0
  Endothelin-converting enzyme 1                                ECE1              P42892           CHEMBL4791      Protease                              0                 6/0
  Toll-like receptor (TLR7/TLR9)                                TLR7              Q9NYK1           CHEMBL5936      Toll-like and Il-1 receptors          0                 1/0
  Glutathione *S*-transferase Mu 1                              GSTM1             P09488           CHEMBL2081      Enzyme                                0                 1/0
  Glutathione *S*-transferase A1                                GSTA1             P08263           CHEMBL3409      Enzyme                                0                 2/0
  Glyoxalase I                                                  GLO1              Q04760           CHEMBL2424      Enzyme                                0                 4/0
  2′-deoxynucleoside 5′-phosphate *N*-hydrolase 1               DNPH1             O43598           CHEMBL3351218   Hydrolase                             0                 1/0
  Cysteinyl leukotriene receptor 1                              CYSLTR1           Q9Y271           CHEMBL1798      Family A G protein-coupled receptor   0                 1/0
  Leukotriene A4 hydrolase                                      LTA4H             P09960           CHEMBL4618      Protease                              0                 3/0
  GABA transporter 1 (by homology)                              SLC6A1            P30531           CHEMBL1903      Electrochemical transporter           0                 2/0
  Serine/threonine-protein kinase PIM1                          PIM1              P11309           CHEMBL2147      Kinase                                0                 4/0
  Serine/threonine-protein kinase PIM2                          PIM2              Q9P1W9           CHEMBL4523      Kinase                                0                 3/0
  Serine/threonine-protein kinase PIM3                          PIM3              Q86V86           CHEMBL5407      Kinase                                0                 3/0
  Tyrosine-protein kinase SRC                                   SRC               P12931           CHEMBL267       Kinase                                0                 3/0
  Folylpoly-gamma-glutamate synthetase                          FPGS              Q05932           CHEMBL3171      Enzyme                                0                 2/0
  DNA (cytosine-5)-methyltransferase 3B                         DNMT3B            Q9UBC3           CHEMBL6095      Reader                                0                 4/0
  Cholesteryl ester transfer protein                            CETP              P11597           CHEMBL3572      Other ion channel                     0                 0/1
  Dipeptidyl peptidase I                                        CTSC              P53634           CHEMBL2252      Protease                              0                 9/0
  Tyrosine-protein kinase ZAP-70                                ZAP70             P43403           CHEMBL2803      Kinase                                0                 1/0
  Histone-lysine *N*-methyltransferase, H3 lysine-79 specific   DOT1L             Q8TEK3           CHEMBL1795117   Writer                                0                 4/0
  Glutathione *S*-transferase Pi                                GSTP1             P09211           CHEMBL3902      Enzyme                                0                 1/0
  Lysine-specific demethylase 4A                                KDM4A             O75164           CHEMBL5896      Eraser                                0                 1/0
  Acyl coenzyme A:cholesterol acyltransferase 1                 SOAT1             P35610           CHEMBL2782      Enzyme                                0                 3/0
  Diacylglycerol *O*-acyltransferase 1                          DGAT1             O75907           CHEMBL6009      Enzyme                                0                 3/0
  Cathepsin K                                                   CTSK              P43235           CHEMBL268       Protease                              0                 1/0
  Glutamate receptor ionotropic kainate 2                       GRIK2             Q13002           CHEMBL3683      Ligand-gated ion channel              0                 1/0
  Lysine-specific demethylase 5A                                KDM5A             P29375           CHEMBL2424504   Eraser                                0                 1/0
  Dihydrofolate reductase                                       DHFR              P00374           CHEMBL202       Oxidoreductase                        0                 2/0
  Nitric-oxide synthase, brain                                  NOS1              P29475           CHEMBL3568      Enzyme                                0                 1/0
  Receptor protein-tyrosine kinase erbB-2                       ERBB2             P04626           CHEMBL1824      Kinase                                0                 1/0
  Adenosine A2a receptor                                        ADORA2A           P29274           CHEMBL251       Family A G protein-coupled receptor   0                 1/0
  Prostanoid EP1 receptor                                       PTGER1            P34995           CHEMBL1811      Family A G protein-coupled receptor   0                 1/0
  Prostanoid FP receptor                                        PTGFR             P43088           CHEMBL1987      Family A G protein-coupled receptor   0                 1/0
  Tryptophan 5-hydroxylase 1                                    TPH1              P17752           CHEMBL5689      Enzyme                                0                 1/0
  Protein farnesyltransferase                                   FNTA FNTB         P49354 P49356    CHEMBL2094108   Enzyme                                0                 0/10
  Glutamate receptor ionotropic kainate 1                       GRIK1             P39086           CHEMBL1918      Ligand-gated ion channel              0                 0/1
  Muscarinic acetylcholine receptor M4                          CHRM4             P08173           CHEMBL1821      Family A G protein-coupled receptor   0                 0/1
  Glucocorticoid receptor                                       NR3C1             P04150           CHEMBL2034      Nuclear receptor                      0                 0/1
  Muscarinic acetylcholine receptor M5                          CHRM5             P08912           CHEMBL2035      Family A G protein-coupled receptor   0                 0/1
  Muscarinic acetylcholine receptor M1                          CHRM1             P11229           CHEMBL216       Family A G protein-coupled receptor   0                 0/1
  Histamine H1 receptor                                         HRH1              P35367           CHEMBL231       Family A G protein-coupled receptor   0                 0/1
  Muscarinic acetylcholine receptor M3                          CHRM3             P20309           CHEMBL245       Family A G protein-coupled receptor   0                 0/1
  Serine/threonine-protein kinase AKT                           AKT1              P31749           CHEMBL4282      Kinase                                0                 0/1
  Geranylgeranyl pyrophosphate synthetase                       GGPS1             O95749           CHEMBL4769      Enzyme                                0                 9/4
  Lysophosphatidic acid receptor 6                              LPAR6             P43657           CHEMBL2331058   Family A G protein-coupled receptor   0                 2/1
  Lysophosphatidic acid receptor Edg-4                          LPAR2             Q9HBW0           CHEMBL3724      Family A G protein-coupled receptor   0                 3/1
  Lysophosphatidic acid receptor 5                              LPAR5             Q9H1C0           CHEMBL5700      Family A G protein-coupled receptor   0                 2/1
  Lysophosphatidic acid receptor 4                              LPAR4             Q99677           CHEMBL5968      Family A G protein-coupled receptor   0                 2/1
  Autotaxin                                                     ENPP2             Q13822           CHEMBL3691      Enzyme                                0                 8/1
  Vanilloid receptor                                            TRPV1             Q8NER1           CHEMBL4794      Voltage-gated ion channel             0                 1/1
  Putative P2Y purinoceptor 10                                  P2RY10            O00398           CHEMBL3562166   Family A G protein-coupled receptor   0                 1/15
  Probable G-protein coupled receptor 34                        GPR34             Q9UPC5           CHEMBL3562165   Family A G protein-coupled receptor   0                 1/6
  Probable G-protein coupled receptor 174                       GPR174            Q9BXC1           CHEMBL3562167   Family A G protein-coupled receptor   0                 1/7

###### 

SwissTargePrediction of the molecular targets of S1P (Isomeric SMILES) in Homo sapiens.

  **Target**                                                    **Common name**   **Uniprot ID**   **ChEMBL ID**   **Target class**                      **Probability**   **Known actives (3D/2D)**
  ------------------------------------------------------------- ----------------- ---------------- --------------- ------------------------------------- ----------------- ---------------------------
  Sphingosine 1-phosphate receptor Edg-8                        S1PR5             Q9H228           CHEMBL2274      Family A G protein-coupled receptor   1                 48/1
  Sphingosine 1-phosphate receptor Edg-5                        S1PR2             O95136           CHEMBL2955      Family A G protein-coupled receptor   1                 10/1
  Sphingosine 1-phosphate receptor Edg-6                        S1PR4             O95977           CHEMBL3230      Family A G protein-coupled receptor   1                 42/1
  Sphingosine 1-phosphate receptor Edg-3                        S1PR3             Q99500           CHEMBL3892      Family A G protein-coupled receptor   1                 99/2
  Sphingosine 1-phosphate receptor Edg-1                        S1PR1             P21453           CHEMBL4333      Family A G protein-coupled receptor   1                 141/2
  Lysophosphatidic acid receptor Edg-7                          LPAR3             Q9UBY5           CHEMBL3250      Family A G protein-coupled receptor   0.097239989       4/10
  Endothelin-converting enzyme 1                                ECE1              P42892           CHEMBL4791      Protease                              0                 7/0
  Sphingosine kinase 2                                          SPHK2             Q9NRA0           CHEMBL3023      Enzyme                                0                 0/2
  Sphingosine kinase 1                                          SPHK1             Q9NYA1           CHEMBL4394      Enzyme                                0                 0/3
  Lysophosphatidic acid receptor Edg-2                          LPAR1             Q92633           CHEMBL3819      Family A G protein-coupled receptor   0                 3/5
  Farnesyl diphosphate synthase                                 FDPS              P14324           CHEMBL1782      Transferase                           0                 11/0
  Glyoxalase I                                                  GLO1              Q04760           CHEMBL2424      Enzyme                                0                 6/0
  NAD-dependent deacetylase sirtuin 1                           SIRT1             Q96EB6           CHEMBL4506      Eraser                                0                 4/0
  Cysteinyl leukotriene receptor 1                              CYSLTR1           Q9Y271           CHEMBL1798      Family A G protein-coupled receptor   0                 1/0
  Glutathione *S*-transferase Mu 1                              GSTM1             P09488           CHEMBL2081      Enzyme                                0                 2/0
  Angiotensin-converting enzyme                                 ACE               P12821           CHEMBL1808      Protease                              0                 7/0
  Neprilysin                                                    MME               P08473           CHEMBL1944      Protease                              0                 8/0
  Indoleamine 2,3-dioxygenase                                   IDO1              P14902           CHEMBL4685      Enzyme                                0                 3/0
  Disks large homolog 4                                         DLG4              P78352           CHEMBL5666      Unclassified protein                  0                 4/0
  DNA (cytosine-5)-methyltransferase 3B                         DNMT3B            Q9UBC3           CHEMBL6095      Reader                                0                 4/0
  Glutathione *S*-transferase A1                                GSTA1             P08263           CHEMBL3409      Enzyme                                0                 2/0
  Carbonic anhydrase II                                         CA2               P00918           CHEMBL205       Lyase                                 0                 22/0
  Carbonic anhydrase I                                          CA1               P00915           CHEMBL261       Lyase                                 0                 20/0
  Carbonic anhydrase XII                                        CA12              O43570           CHEMBL3242      Lyase                                 0                 6/0
  Carbonic anhydrase IX                                         CA9               Q16790           CHEMBL3594      Lyase                                 0                 6/0
  Squalene synthetase (by homology)                             FDFT1             P37268           CHEMBL3338      Enzyme                                0                 6/0
  Thrombin and coagulation factor X                             F10               P00742           CHEMBL244       Protease                              0                 3/0
  Dipeptidyl peptidase I                                        CTSC              P53634           CHEMBL2252      Protease                              0                 7/0
  Glutamate receptor ionotropic kainate 2                       GRIK2             Q13002           CHEMBL3683      Ligand-gated ion channel              0                 2/0
  Serine/threonine-protein kinase PIM1                          PIM1              P11309           CHEMBL2147      Kinase                                0                 4/0
  Glutathione *S*-transferase Pi                                GSTP1             P09211           CHEMBL3902      Enzyme                                0                 3/0
  Serine/threonine-protein kinase PIM2                          PIM2              Q9P1W9           CHEMBL4523      Kinase                                0                 3/0
  Serine/threonine-protein kinase PIM3                          PIM3              Q86V86           CHEMBL5407      Kinase                                0                 3/0
  Leukotriene A4 hydrolase                                      LTA4H             P09960           CHEMBL4618      Protease                              0                 7/0
  Cholesteryl ester transfer protein                            CETP              P11597           CHEMBL3572      Other ion channel                     0                 0/1
  Caspase-1                                                     CASP1             P29466           CHEMBL4801      Protease                              0                 2/0
  Tryptophan 5-hydroxylase 1                                    TPH1              P17752           CHEMBL5689      Enzyme                                0                 1/0
  Histone-lysine *N*-methyltransferase, H3 lysine-79 specific   DOT1L             Q8TEK3           CHEMBL1795117   Writer                                0                 2/0
  Calcium sensing receptor                                      CASR              P41180           CHEMBL1878      Family C G protein-coupled receptor   0                 3/0
  EZH2/SUZ12/EED/RBBP7/RBBP4                                    EZH2              Q15910           CHEMBL2189110   Writer                                0                 1/0
  2′-deoxynucleoside 5′-phosphate *N*-hydrolase 1               DNPH1             O43598           CHEMBL3351218   Hydrolase                             0                 2/0
  Transmembrane protease serine 11D                             TMPRSS11D         O60235           CHEMBL1795138   Protease                              0                 1/0
  Thrombin                                                      F2                P00734           CHEMBL204       Protease                              0                 1/0
  Glycogen synthase kinase-3 beta                               GSK3B             P49841           CHEMBL262       Kinase                                0                 1/0
  Matriptase                                                    ST14              Q9Y5Y6           CHEMBL3018      Protease                              0                 1/0
  Matrix metalloproteinase 2                                    MMP2              P08253           CHEMBL333       Protease                              0                 1/0
  Matrix metalloproteinase 12                                   MMP12             P39900           CHEMBL4393      Protease                              0                 1/0
  Matrix metalloproteinase 8                                    MMP8              P22894           CHEMBL4588      Protease                              0                 1/0
  Glutamate receptor ionotropic kainate 3                       GRIK3             Q13003           CHEMBL3684      Ligand-gated ion channel              0                 1/0
  GABA transporter 1 (by homology)                              SLC6A1            P30531           CHEMBL1903      Electrochemical transporter           0                 2/0
  Integrin alpha-V/beta-3                                       ITGAV ITGB3       P06756 P05106    CHEMBL1907598   Membrane receptor                     0                 1/0
  Cathepsin K                                                   CTSK              P43235           CHEMBL268       Protease                              0                 1/0
  Tyrosine-protein kinase ZAP-70                                ZAP70             P43403           CHEMBL2803      Kinase                                0                 1/0
  Caspase-3                                                     CASP3             P42574           CHEMBL2334      Protease                              0                 1/0
  Aminopeptidase N                                              ANPEP             P15144           CHEMBL1907      Protease                              0                 1/0
  Integrin alpha-5/beta-1                                       ITGB1 ITGA5       P05556 P08648    CHEMBL2095226   Membrane receptor                     0                 1/0
  C3a anaphylatoxin chemotactic receptor                        C3AR1             Q16581           CHEMBL4761      Family A G protein-coupled receptor   0                 1/0
  Endoplasmic reticulum aminopeptidase 2                        ERAP2             Q6P179           CHEMBL5043      Protease                              0                 1/0
  Endoplasmic reticulum aminopeptidase 1                        ERAP1             Q9NZ08           CHEMBL5939      Protease                              0                 1/0
  Prostanoid EP4 receptor (by homology)                         PTGER4            P35408           CHEMBL1836      Family A G protein-coupled receptor   0                 1/0
  Protein farnesyltransferase                                   FNTA FNTB         P49354 P49356    CHEMBL2094108   Enzyme                                0                 0/10
  Muscarinic acetylcholine receptor M4                          CHRM4             P08173           CHEMBL1821      Family A G protein-coupled receptor   0                 0/1
  Glucocorticoid receptor                                       NR3C1             P04150           CHEMBL2034      Nuclear receptor                      0                 0/1
  Muscarinic acetylcholine receptor M5                          CHRM5             P08912           CHEMBL2035      Family A G protein-coupled receptor   0                 0/1
  Muscarinic acetylcholine receptor M1                          CHRM1             P11229           CHEMBL216       Family A G protein-coupled receptor   0                 0/1
  Histamine H1 receptor                                         HRH1              P35367           CHEMBL231       Family A G protein-coupled receptor   0                 0/1
  Muscarinic acetylcholine receptor M3                          CHRM3             P20309           CHEMBL245       Family A G protein-coupled receptor   0                 0/1
  Serine/threonine-protein kinase AKT                           AKT1              P31749           CHEMBL4282      Kinase                                0                 0/1
  Geranylgeranyl pyrophosphate synthetase                       GGPS1             O95749           CHEMBL4769      Enzyme                                0                 12/4
  Lysophosphatidic acid receptor 6                              LPAR6             P43657           CHEMBL2331058   Family A G protein-coupled receptor   0                 2/1
  Lysophosphatidic acid receptor Edg-4                          LPAR2             Q9HBW0           CHEMBL3724      Family A G protein-coupled receptor   0                 3/1
  Lysophosphatidic acid receptor 5                              LPAR5             Q9H1C0           CHEMBL5700      Family A G protein-coupled receptor   0                 2/1
  Lysophosphatidic acid receptor 4                              LPAR4             Q99677           CHEMBL5968      Family A G protein-coupled receptor   0                 2/1
  Putative P2Y purinoceptor 10                                  P2RY10            O00398           CHEMBL3562166   Family A G protein-coupled receptor   0                 3/15
  Probable G-protein coupled receptor 34                        GPR34             Q9UPC5           CHEMBL3562165   Family A G protein-coupled receptor   0                 3/6
  Autotaxin                                                     ENPP2             Q13822           CHEMBL3691      Enzyme                                0                 5/1
  Vanilloid receptor                                            TRPV1             Q8NER1           CHEMBL4794      Voltage-gated ion channel             0                 1/1
  Probable G-protein coupled receptor 174                       GPR174            Q9BXC1           CHEMBL3562167   Family A G protein-coupled receptor   0                 2/7
  Glutamate receptor ionotropic kainate 1                       GRIK1             P39086           CHEMBL1918      Ligand-gated ion channel              0                 1/1
  Enteropeptidase                                               TMPRSS15          P98073           CHEMBL1741195   Protease                              0                 2/0
  Trypsin I                                                     PRSS1             P07477           CHEMBL209       Protease                              0                 2/0
  Vascular endothelial growth factor receptor 2                 KDR               P35968           CHEMBL279       Kinase                                0                 1/0
  Carbonic anhydrase IV                                         CA4               P22748           CHEMBL3729      Lyase                                 0                 10/0
  Thymidylate synthase (by homology)                            TYMS              P04818           CHEMBL1952      Transferase                           0                 3/0
  Acyl coenzyme A:cholesterol acyltransferase 1                 SOAT1             P35610           CHEMBL2782      Enzyme                                0                 4/0
  Diacylglycerol *O*-acyltransferase 1                          DGAT1             O75907           CHEMBL6009      Enzyme                                0                 5/0
  Metastin receptor                                             KISS1R            Q969F8           CHEMBL5413      Family A G protein-coupled receptor   0                 2/0
  Dihydrofolate reductase                                       DHFR              P00374           CHEMBL202       Oxidoreductase                        0                 1/0
  Integrin alpha-IIb/beta-3                                     ITGA2B ITGB3      P08514 P05106    CHEMBL2093869   Membrane receptor                     0                 1/0
  Growth factor receptor-bound protein 2                        GRB2              P62993           CHEMBL3663      Other cytosolic protein               0                 1/0
  MAP kinase ERK2 (by homology)                                 MAPK1             P28482           CHEMBL4040      Kinase                                0                 1/0
  MAP kinase p38 alpha (by homology)                            MAPK14            Q16539           CHEMBL260       Kinase                                0                 1/0
  Folylpoly-gamma-glutamate synthetase (by homology)            FPGS              Q05932           CHEMBL3171      Enzyme                                0                 1/0

![Swiss Target Prediction for sphingosine-1-phosphate (S1P). Top 15 percent of the molecular targets (Homo sapiens) of S1P obtained using both canonical and isomeric Simplified Molecular Input Line Entry System (SMILES) codes in Swiss Target Prediction server.](fcell-08-00444-g001){#F1}

Over Representation Analysis (ORA) of the Molecular Targets of S1P Using WebGestalt {#S3.SS2}
-----------------------------------------------------------------------------------

All the 93 molecular targets of S1P obtained using isomeric SMILES were used as input molecules in WebGestalt Open Source Tool to perform the ORA. GO Slim Summary for S1P Molecular Targets in Humans showing Biological Process, Cellular Component, and Molecular Function category in the red, blue, and green bar, respectively. The height of the bar represents the number of IDs in the user list and also in the category ([Figure 2](#F2){ref-type="fig"}). The query list had 93 targets of S1P in which 89 were mapped to 89 unique Entrez gene IDs unambiguously, and the remaining 4 could not be mapped to any Entrez gene ID. Therefore, the GO Slim summary was established upon the 89 distinctive Entrez gene IDs ([Figure 2](#F2){ref-type="fig"}). The reference list was mapped to 61506 Entrez gene IDs and 16671 IDs were annotated to the selected functional categories that were used as the reference for the enrichment analysis. The GO Biological Processes such as sphingolipid mediated signaling pathway, S1P receptor signaling pathway, chemical homeostasis, positive regulation of cytosolic calcium ion concentration, and cellular calcium ion homeostasis, and phospholipase C-activating G protein-coupled receptor signaling pathway were significantly regulated (*P* \< 0.01; *Q* \< 0.01) in ORA ([Table 2](#T3){ref-type="table"}). The GO Molecular Functions such as the bioactive lipid receptor activity, S1P receptor activity, transmembrane signaling receptor activity, molecular transducer activity, G protein-coupled receptor activity, etc. were significantly regulated (*P* \< 0.01; *Q* \< 0.01) in the ORA ([Table 3](#T4){ref-type="table"}). The molecules involved in the bioactive receptor activity (GO:0045125) comprise of GPR174, LPAR1, LPAR2, LPAR3, LPAR4, S1PR1, S1PR2, S1PR3, S1PR4, S1PR5, SPHK1, and SPHK2 ([Table 4](#T5){ref-type="table"}).

![Over Representation Analysis (ORA) using Web-based Gene Set Analysis Toolkit (WebGestalt). GO Slim Summary for S1P molecular targets in humans showing Biological Process, Cellular Component, and Molecular Function categories in the red, blue, and green bar, respectively. The height of the bar represents the number of IDs in the user list and also in the GO category.](fcell-08-00444-g002){#F2}

###### 

The biological processes regulated by the molecular targets of S1P in Homo sapiens.

  **Gene set**   **Description**                                                                                                                         **Size**   **Expect**   **Ratio**   ***P*-value**   **FDR**
  -------------- --------------------------------------------------------------------------------------------------------------------------------------- ---------- ------------ ----------- --------------- ------------
  GO:0003376     Sphingosine-1-phosphate receptor signaling pathway                                                                                      10         0.053402     131.08      1.1546e-14      1.0497e-10
  GO:0090520     Sphingolipid mediated signaling pathway                                                                                                 11         0.058742     119.16      3.1530e-14      1.4332e-10
  GO:0007200     Phospholipase C-activating G protein-coupled receptor signaling pathway                                                                 96         0.51266      23.407      1.0836e-13      3.2836e-10
  GO:0050801     Ion homeostasis                                                                                                                         776        4.1440       6.0328      1.6986e-13      3.8606e-10
  GO:0007186     G protein-coupled receptor signaling pathway                                                                                            1290       6.8889       4.5000      2.6357e-13      4.5957e-10
  GO:0048878     Chemical homeostasis                                                                                                                    1119       5.9757       4.8530      3.0331e-13      4.5957e-10
  GO:0051482     Positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway   31         0.16555      48.325      3.4222e-12      4.4444e-9
  GO:0007204     Positive regulation of cytosolic calcium ion concentration                                                                              301        1.6074       9.9539      4.6408e-12      5.2737e-9
  GO:0006874     Cellular calcium ion homeostasis                                                                                                        439        2.3444       7.6780      1.4333e-11      1.4478e-8

###### 

The molecular processes regulated by the molecular targets of S1P in Homo sapiens.

  **Gene set**   **Description**                                                     **Size**   **Expect**   **Ratio**   ***P*-value**   **FDR**
  -------------- ------------------------------------------------------------------- ---------- ------------ ----------- --------------- ------------
  GO:0045125     Bioactive lipid receptor activity                                   14         0.074741     160.56      0               0
  GO:0038036     Sphingosine-1-phosphate receptor activity                           8          0.042709     163.90      7.7716e-16      7.2936e-13
  GO:0004930     G protein-coupled receptor activity                                 806        4.3029       6.2748      5.4401e-15      3.4037e-12
  GO:0038023     Signaling receptor activity                                         1429       7.6289       4.4568      1.5210e-14      7.1373e-12
  GO:0004888     Transmembrane signaling receptor activity                           1211       6.4651       4.7950      4.7962e-14      1.5594e-11
  GO:0060089     Molecular transducer activity                                       1488       7.9439       4.2800      4.9849e-14      1.5594e-11
  GO:0004175     Endopeptidase activity                                              436        2.3276       7.7332      1.2733e-11      3.4142e-9
  GO:0070011     Peptidase activity, acting on [L]{.smallcaps}-amino acid peptides   610        3.2566       6.1415      5.0832e-11      1.1927e-8
  GO:0008233     Peptidase activity                                                  634        3.3847       5.9090      1.0096e-10      2.1055e-8
  GO:0008236     Serine-type peptidase activity                                      204        1.0891       11.019      8.4807e-10      1.5918e-7

###### 

The genes involved in the bioactive receptor activity (GO:0045125) regulated by S1P in Homo sapiens.

  **Gene symbol**   **Gene Name**                        **Entrez Gene ID**
  ----------------- ------------------------------------ --------------------
  GPR174            G protein-coupled receptor 174       84636
  LPAR1             Lysophosphatidic acid receptor 1     1902
  LPAR2             Lysophosphatidic acid receptor 2     9170
  LPAR3             Lysophosphatidic acid receptor 3     23566
  LPAR4             Lysophosphatidic acid receptor 4     2846
  S1PR1             Sphingosine-1-phosphate receptor 1   1901
  S1PR2             Sphingosine-1-phosphate receptor 2   9294
  S1PR3             Sphingosine-1-phosphate receptor 3   1903
  S1PR4             Sphingosine-1-phosphate receptor 4   8698
  S1PR5             Sphingosine-1-phosphate receptor 5   53637
  SPHK1             Sphingosine kinase 1                 8877
  SPHK2             sphingosine kinase 2                 56848

Identification of S1P-Induced Molecular Targets in Asthma and Other Respiratory Diseases {#S3.SS3}
----------------------------------------------------------------------------------------

Then, we used the Open Targets Platform to find the S1P molecular targets associated with respiratory diseases. Our findings showed that about 109 types of respiratory diseases were significantly (*P* \< 0.05) affected by the molecular targets of S1P. The top 15 respiratory diseases significantly (*P* \< 0.01; *Q* \< 0.01) induced by S1P and its molecular targets were lung disease, respiratory system disease, respiratory system neoplasm, bronchial disease, lung carcinoma, asthma, interstitial lung disease, COPD, Rare genetic respiratory disease, idiopathic pulmonary fibrosis, pulmonary fibrosis, acute lung injury, pneumonia, whooping cough, and non-small cell lung adenocarcinoma ([Table 5](#T6){ref-type="table"}).

###### 

Top 15 respiratory diseases associated with the molecular targets of S1P.

  **Disease full name**                   **Relevance (*p*-value)**   **Number of associated targets**   **Therapeutic area**                             **Highest associated targets (max 10)**
  --------------------------------------- --------------------------- ---------------------------------- ------------------------------------------------ -----------------------------------------------------------------
  Lung disease                            6.00E-42                    82                                 Respiratory system disease                       KDR TYMS CHRM3 MMP8 NR3C1 CHRM1 AKT1 CA4 ACE MMP2...
  Respiratory system disease              2.00E-39                    84                                 Respiratory system disease                       KDR TYMS CHRM3 MMP8 HRH1 NR3C1 CHRM1 AKT1 CA4 MMP2...
  Respiratory system neoplasm             2.00E-38                    77                                 Neoplasm, respiratory system disease             KDR TYMS NR3C1 AKT1 MMP2 DHFR FDPS GRB2 MMP8 MMP12...
  Bronchial disease                       2.00E-38                    58                                 Respiratory system disease                       NR3C1 CYSLTR1 HRH1 CHRM1 CHRM3 DHFR GSTM1 MAPK14 CASP1 S1PR2...
  Lung carcinoma                          5.00E-38                    78                                 Neoplasm, respiratory system disease             KDR TYMS NR3C1 AKT1 MMP2 DHFR FDPS GRB2 MMP12 IDO1...
  Asthma                                  1.00E-35                    55                                 Respiratory system disease                       NR3C1 CYSLTR1 HRH1 CHRM3 CHRM1 DHFR GSTM1 MAPK14 CASP1 S1PR2...
  Interstitial lung disease               3.00E-32                    43                                 Respiratory system disease                       NR3C1 KDR MMP8 CTSK EZH2 SOAT1 CYSLTR1 SIRT1 CASP3 MMP12...
  Chronic obstructive pulmonary disease   8.00E-32                    48                                 Respiratory system disease                       CHRM3 MMP8 ACE NR3C1 CA1 CHRM1 CA12 CA4 CA2 MMP12...
  Rare genetic respiratory disease        3.00E-31                    44                                 Genetic disorder, respiratory system disease     MMP8 FDPS NR3C1 CHRM3 SIRT1 PRSS1 EZH2 CTSK HRH1 KISS1R...
  Idiopathic pulmonary fibrosis           2.00E-29                    39                                 Neoplasm, respiratory system disease             NR3C1 KDR MMP8 CTSK EZH2 SOAT1 CASP3 MMP2 ANPEP TYMS...
  Pulmonary fibrosis                      7.00E-29                    37                                 Neoplasm, respiratory system disease             NR3C1 KDR MMP8 CTSK EZH2 SOAT1 CASP3 MMP12 ANPEP MMP2...
  Acute lung injury                       9.00E-28                    32                                 Respiratory system disease                       MAPK14 MMP8 MMP2 GSK3B IDO1 S1PR1 SIRT1 CASP1 CASP3 SOAT1...
  Pneumonia                               2.00E-27                    37                                 Infectious disease, respiratory system disease   MMP8 NR3C1 CHRM3 CHRM1 MMP12 ACE DHFR SOAT1 F2 MMP2...
  Whooping cough                          3.00E-27                    32                                 Infectious disease, respiratory system disease   CASP1 CASP3 AKT1 CA1 S1PR4 S1PR1 MAPK1 HRH1 MMP2 TRPV1...
  Non-small cell lung adenocarcinoma      3.00E-26                    42                                 Neoplasm, respiratory system disease             SIRT1 EZH2 CASR GSK3B TYMS MMP2 IDO1 KDR CASP3 CA9...

Ingenuity Pathway Analysis of the Differentially Regulated Gene Networks by S1P/S1PR Axis in Respiratory Diseases {#S3.SS4}
-----------------------------------------------------------------------------------------------------------------

Next, we utilized the IPA to deduce the canonical pathways, upstream regulators, causal functions, diseases, and bio functions, and non-directional unique networks significantly impacted by the S1P mediated signaling molecules. The IPA core analysis of the molecular targets of S1P revealed that the canonical pathways such as eNOS signaling, S1P signaling, GPCRs signaling, ceramide signaling, G a12/13 signaling, human embryonic stem cell pluripotency, and endocannabinoid cancer inhibition pathway ([Figure 3](#F3){ref-type="fig"}) were potentially regulated (*P* \< 0.05). About 263 molecules play a significant role (*P* \< 0.05) as upstream regulators of the molecular targets of S1P ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}). Furthermore, we have filtered the upstream regulators based on the molecule types such as cytokines, and growth factors using the IPA. The cytokines such as Interleukin-13 (IL-13), Interferon-gamma (IFN-γ), IFN-β1, Tumor Necrosis Factor-alpha (TNF-α), Interleukin-4 (IL-4), Interleukin-5 (IL-5), Interleukin-1 (IL-1β), Interleukin-21 (IL-21), Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) that has cytokine-like activity, and cytokine-inducing Corticotropin-Releasing Hormone (CRH) were found to be the upstream regulators of the S1P signaling. The growth factors such as Hepatocyte Growth Factor (HGF), Vascular Endothelial Growth Factors (VEGF), Colony Stimulating Factor 1 (CSF1) or Macrophage Colony-Stimulating Factor (M-CSF), Colony Stimulating Factor-2 (CSF2) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), VEGF-A, VEGF-B, VEGF-D, Fibroblast Growth Factor 16 (FGF16), Insulin-like Growth Factor (IGF), and Transforming Growth Factor-beta 1 (TGF-β1) were identified as the upstream regulators of S1P signaling ([Table 6](#T7){ref-type="table"}).

![Canonical pathways regulated by the molecular targets of S1P. The IPA core analysis of the molecular targets of S1P revealed that the canonical pathways such as eNOS signaling, sphingosine-1-phosphate signaling, G-protein coupled receptor signaling, ceramide signaling, G a12/13 signaling, human embryonic stem cell pluripotency, and endocannabinoid cancer inhibition pathway were potentially regulated (*P* \< 0.05).](fcell-08-00444-g003){#F3}

###### 

Upstream regulators of the S1P molecular targets -- Focus on cytokines and growth Factors.

  **Upstream regulator**   **Molecule type**   ***p*-value of overlap**   **Target molecules in dataset**
  ------------------------ ------------------- -------------------------- ----------------------------------------------------
  HGF                      Growth factor       0.000000328                AKT1, CA9, CTSK, MAPK14, MMP2, MMP8, ST14
  IL13                     Cytokine            0.0000174                  C3AR1, CASP1, CTSC, CYSLTR1, ENPP2, LTA4H, ST14
  IFNG                     Cytokine            0.000145                   ACE, CASP1, CASP3, ERAP2, IDO1, MMP2, PIM1, SOAT1
  IFNB1                    Cytokine            0.000528                   CASP1, CASP3, IDO1
  VEGFA                    Growth factor       0.000775                   KDR, MMP12, MMP2
  TNF                      Cytokine            0.00118                    CTSC, GSTA1, IDO1, MMP12, MMP2, MMP8, NR3C1, SOAT1
  IL4                      Cytokine            0.00132                    CYSLTR1, IDO1, PIM1, ST14
  VEGFB                    Growth factor       0.0044                     MMP12
  CSF1                     Growth factor       0.00767                    CTSK, MMP12
  LIF                      Cytokine            0.0131                     ERAP1
  CSF2                     Growth factor       0.0133                     CASP3, CTSC, PIM1
  CRH                      Cytokine            0.0175                     TPH1
  FGF16                    Growth factor       0.0175                     MMP2
  VEGFD                    Growth factor       0.0175                     MMP12
  TGFB1                    Growth factor       0.0195                     KDR, MAPK1, MMP12, MMP2, SPHK1
  IL5                      Cytokine            0.0197                     CTSC, PIM1
  IL1B                     Cytokine            0.0236                     GSTA1, KDR, MMP12, MMP8
  IL21                     Cytokine            0.0296                     IDO1, MMP2
  TIMP1                    Cytokine            0.0389                     MME
  IGF2                     Growth factor       0.0389                     MMP12

Validation of Biomarkers in Asthma Using Luminex xMAP Technology {#S3.SS5}
----------------------------------------------------------------

Besides, we have used the Luminex xMAP assay to validate the cytokines and growth factors that were upstream of the S1P signaling in asthma. Here, we have analyzed the levels of cytokines such as IL-13, IFN-γ, TNF-α, IL-4, IL-5, and IL-1β ([Figure 4](#F4){ref-type="fig"}) and growth factors such as HGF, VEGF, and CSF2 or GM-CSF along with the estimation of serum S1P concentration in asthma patients compared with the healthy controls ([Figure 5](#F5){ref-type="fig"}). The clinical and laboratory characteristics of asthma patients and healthy controls were given in [Table 7](#T8){ref-type="table"}. The upstream regulator cytokines of S1P signaling such as IL-13, IFN-γ, TNF-α, IL-4, IL-5, and IL-1β were significantly (*P* \< 0.01) increased in the serum of asthma patients compared the healthy controls. Similarly, the growth factors that were found to be upstream of S1P signaling such as HGF, VEGF, and CSF2 were significantly (*P* \< 0.01) increased in the serum of asthma patients compared to the healthy controls. The S1P levels were significantly increased in the serum of asthma patients compared to the healthy controls. All the cytokines and growth factors analyzed by the Luminex xMAP assay were positively correlated with the S1P levels in the serum of asthmatics ([Supplementary Table S2](#TS2){ref-type="supplementary-material"}).

![Luminex xMAP assay to validate the cytokines that were upstream of the S1P signaling in asthma. The upstream regulator cytokines of S1P signaling such as IL-13 **(A)**, IFN-γ **(B)**, TNF-α **(C)**, IL-1β **(D)**, IL-4 **(E)**, and IL-5 **(F)** were significantly (*T*-test ^∗∗^*P* \< 0.01, *F*-test ^\#^*P* \< 0.05, and ^\#\#^*P* \< 0.01) elevated in the serum of asthma patients compared the healthy controls.](fcell-08-00444-g004){#F4}

![Luminex xMAP assay to validate the growth factors that were upstream of the S1P signaling in asthma. The growth factors that were found to be upstream of S1P signaling such as **(A)** HGF, **(B)** VEGF, **(C)** CSF2, and **(D)** S1P were significantly (*T*-test ^∗∗^*P* \< 0.01, *F*-test ^\#^*P* \< 0.05, and ^\#\#^*P* \< 0.01) elevated in the serum of asthma patients compared to the healthy controls.](fcell-08-00444-g005){#F5}

###### 

Clinical and laboratory parameters in healthy control and asthma patients.

  **Clinical Parameters**    **Healthy (*n* = 12)**   **Asthma (*n* = 12)**
  -------------------------- ------------------------ -----------------------
  Age (Years)                34 (23 -- 48)            33 (22 -- 45)
  Disease Duration (Years)   NA                       8.5 (5 -- 10)
  Serum IgE (IU/L)           22 (14 -- 65)            365 (79 -- 621)
  WBC Count (10^9^/L)        6.75 (5.2 -- 7.3)        7.1 (5.7 -- 8.1)
  Eosinophils (percentage)   0.14 (0.11 -- 0.19)      5.5 (3 -- 10)
  FEV1(Liter)                NA                       2.3 (1.9 -- 2.9)

NA, either data not available or not applicable. The table shows data as medians with the range indicated in the parentheses.

Discussion {#S4}
==========

In the present study, to decode the biological and molecular functions of bioactive lipid molecule, S1P in the development of asthma and other respiratory diseases, we have applied both next-generation knowledge discovery platforms such as SwissTargetPrediction, WebGestalt, Open Targets Platform, and IPA and validated the key upstream regulators of S1P signaling using Luminex xMAP technology. Currently, knowledge discovery and big data analytical platforms are swiftly transforming the Biomedical Research landscape ([@B8]; [@B38]). All the chemical or biochemical compounds with pharmacological or pathological actions influencing diagnosis, treatment, or recuperation, and prevention of a disease can be used in next-generation knowledge discovery platforms using a unique SMILES code ([@B56]; [@B43]). SMILES, postulated by David Weininger, is a chemical annotation method that symbolizes a simple molecule structure ([@B56]; [@B43]). Here, we have used the isomeric SMILES of S1P to deduce its downstream molecular targets using the SwissTargetPrediction server ([@B13]; [@B10]; [@B9]).

Several studies have shown that S1P augments airway hyperactivity, bronchoconstriction, and airway remodeling in asthma and other related respiratory diseases ([@B45]; [@B39]; [@B28]) and the S1P receptors are differentially expressed in the lymphoid tissues, dendritic cells, and the lung ([@B1]). S1P is an effective biologically active paracrine mediator that regulates various cellular functions such as apoptosis, cell growth, cell proliferation, immune regulation, etc. ([@B26]; [@B1]). Here, we have further identified that biological processes such as S1PR signaling pathway, sphingolipid mediated signaling pathway, chemical homeostasis, positive regulation of cytosolic calcium ion concentration, and cellular calcium ion homeostasis were regulated by S1P. Importantly, the interaction of S1P with the five types of S1PRs and four types of LPARs on the plasma membrane triggers an intracellular cascade of reactions leading to the biosynthesis of various pro-inflammatory mediators that contribute to the pathogenicity in asthma. Also, the S1P regulates various molecular functions that are essential for the pathogenesis of asthma and respiratory diseases such as the bioactive lipid receptor activity, S1P receptor activity, G protein-coupled receptor activity, signaling receptor activity, transmembrane signaling receptor activity, molecular transducer activity, endopeptidase activity, peptidase activity acting on L-amino acid peptides, peptidase activity, and serine-type peptidase activity. We found that the S1P signaling was associated with more than 100 types of respiratory diseases such as lung disease, respiratory system disease, respiratory system neoplasm, bronchial disease, lung carcinoma, asthma, interstitial lung disease, COPD, rare genetic respiratory disease, idiopathic pulmonary fibrosis, pulmonary fibrosis, acute lung injury, pneumonia, whooping cough, non-small cell lung adenocarcinoma, etc., Besides, the S1P levels were found to be increased in the bronchoalveolar lavage fluids of allergic asthma patients and were also positively associated with augmented airway inflammation ([@B3]; [@B20]). Altered sphingolipid metabolism according to the phenotype and genotype of asthma was deduced using metabolic studies in asthma patients ([@B31]; [@B20]). Similarly, the sphingolipid metabolism was found to be disturbed in aspirin-exacerbated respiratory disease (AERD), a serious type of adult-onset eosinophilic asthma ([@B51]; [@B44]).

In the present study, we have found several upstream regulators of S1P signaling including various cytokines such as IL-13, IFN-γ, IFN-β1, TNF-α, IL-4, IL-5, IL-1β, IL-21, TIMP-1, and CRH, and growth factors such as HGF, VEGF, CSF1, CSF2, VEGF-A, VEGF-B, VEGF-D, FGF16, IGF, and TGFβ1. Using multiplex xMAP technology, we have further validated that the levels of the upstream cytokines of S1P signaling such as IL-13, IFN-γ, TNF-α, IL-4, IL-5, and IL-1β were increased in the serum of asthma patients. Similarly, the growth factors such as HGF, VEGF, and CSF2 were increased in the serum of asthmatic patients. To further decode the association of the upstream cytokines and growth factors with S1P, we have estimated the S1P concentration in the serum of asthmatics. The levels of cytokines and growth factors analyzed using xMAP technology positively correlated with the S1P levels in the serum of asthmatics which further vouch for the significance of S1P signaling in the pathogenicity of asthma.

Asthma is a chronic disease and the incidence is ever-increasing around the globe ([@B2]). Most of the asthmatics have disease exacerbation caused by the Th2 type of immune cells compared to other types such as T-helper type 1 (Th1) and T-helper type 17 (Th17) and other immune cells such as mast cells, eosinophils, and bronchial smooth muscles, myofibroblasts and epithelial cells ([@B29]). The Th2 associated cytokines play a vital role in the development of allergy and airway remodeling in asthma ([@B22]). The asthmatics studied here had more eosinophils in their blood and the levels of Th2 serum cytokines such as IL-4, IL-5, and IL-13 were increased compared to the healthy controls. Here, most of the cytokines and growth factors examined were associated positively with an increase in the serum S1P. The sphingosine kinases regulate the expression of Th2, Th1, Th17, chemokines, and an array of other pro-inflammatory factors by catalyzing the conversion of sphingosine into S1P ([@B36]; [@B1]). Many asthmatics have an uncontrolled disease state even though they are under a treatment regimen which could be due to the increased production of S1P ([@B1]) and a recent study found that ceramide/S1P rheostat was indeed dysregulated in uncontrolled asthma ([@B21]). Hence, it is prudent that the ceramide/S1P production may be targeted in controlling the airway inflammation in asthma ([@B21]). Importantly, the *in silico* results obtained using our next generation knowledge discovery pipeline coupled with xMAP assay also showed a potential association of S1P in asthma and other respiratory diseases which is detrimental for the patients due to its ability to trigger an array of cytokines, chemokines, and growth factors. More importantly, an increase in the upstream regulator Th2 cytokines such as IL-4, IL-5, and IL-13 is potentially harmful to asthmatics and play an underlying role in the disease pathogenesis. Similarly, the growth factors such as VEGF, CSF2, and HGF were found to be increased in asthmatics and may also be responsible for making the disease chronically worse. A recent study showed that the inhibition of S1P receptors potentially augments the inhibition of VEGF ([@B12]). The S1P/S1PR signaling was regulated through the activation of SPHK1 and SPHK 2 to produce S1P by the phosphorylation of sphingosine ([@B36]; [@B1]) and the airway hyperresponsiveness and inflammation was potentially reduced by SPHK inhibitors and FTY720, a synthetic analog of S1P and S1PR agonist ([@B1]) and other S1PR modulators ([@B30]), in animal models of allergic asthma ([@B47]; [@B18]; [@B40]).

We conclude that the S1P and its associated signaling molecules, either upstream or downstream, are pharmacological targets of great significance for the development of novel drugs for asthma and other related respiratory diseases in humans. However, one of the critical limitations of this study is the less number of samples used for the validation of biomarkers in the serum associated with S1P signaling in asthma. In future, we will be collecting more samples from patients suffering from atopic and non-atopic asthma and other respiratory diseases and disorders with varying severity that undergo different treatment regimens, for further validation of upstream regulator molecules associated with S1P signaling along with the key cytokines, chemokines, and growth factors that play a crucial role in the pathogenesis of an array of respiratory diseases and disorders.
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###### 

The flow diagram illustrates the essential steps in the *in silico* experiments using next-generation knowledge discovery platforms to uncover the molecular targets of S1P and their association with various respiratory diseases and disorders and the subsequent validation of disease-specific biomarkers and their relationship with S1P in Asthma.
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Click here for additional data file.

###### 

The list of 263 upstream regulators identified based on the IPA core analysis of the molecular targets of S1P.
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Click here for additional data file.

###### 

Simple linear regression analysis of S1P with upstream regulatory cytokines and growth factors in asthma patients.
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Click here for additional data file.
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